Eye Diseases: News and Research on Glaucoma

MeSH tree: C11.525.381

NRTI use linked to risk for primary open-angle glaucoma

Use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) is associated with an increased risk for primary open-angle glaucoma (POAG), according to a study published online June 20 in Ophthalmology.

Vitamin supplements may slow down the progression of glaucoma

A vitamin supplement that improves metabolism in the eye appears to slow down damage to the optic nerve in glaucoma. The promising results have been published in the journal Cell Reports Medicine. The researchers behind the ...

page 4 from 16